LOGO
LOGO

Intraday Alerts

SciSparc Stock Rises 34% After Subsidiary NeuroThera Labs Completes Acquisition Of CliniQuantum

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us

Shares of SciSparc Ltd. (SPRC) are climbing around 34 percent in Thursday morning trading after the company's subsidiary NeuroThera Labs Inc. acquired approximately 54% interest in CliniQuantum Ltd. in exchange of common shares valued at about C$9.5 million.

The company's shares are currently trading at $12.68 on the Nasdaq, up 34.63 percent. The stock opened at $13.52 and has climbed as high as $14.07 so far in today's session. Over the past year, it has traded in a range of $2.98 to $80.10.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Biotech Stocks by Subscribing to RTT Biotech Investor.
Global Economics Weekly Update -May 18 – May 22, 2026

May 22, 2026 14:46 ET
Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.

Latest Updates on COVID-19